Skip to main content
Clinical Trials/NCT04511182
NCT04511182
Unknown
N/A

Early Individualized-exercise Based Cardiac Rehabilitation Program in Patients With a Recent Acute Myocardial Infarction (EARLYmyo-CRPⅡ): Study Protocol for a Randomised Controlled Trial

RenJi Hospital1 site in 1 country160 target enrollmentFebruary 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Acute Myocardial Infarction
Sponsor
RenJi Hospital
Enrollment
160
Locations
1
Primary Endpoint
Peak oxygen consumption (VO2)change
Last Updated
5 years ago

Overview

Brief Summary

Acute myocardial infarction (AMI) is a life-threatening condition and a cause of functional disability. After reperfusion therapies and pharmacological strategies, patients suffered great pain physically and mentally. How to improve the quality of life and the prognosis in patients with AMI is a hot topic in the field of cardiac rehabilitation now. In this study, a randomized, controlled and prospective clinical trial is designed for patients with AMI to improve exercise capacity, cardiometabolic parameters, as well as quality of life by an individualized, low-cost exercise intervention we developed after evaluation by Cardiopulmonary Exercise Tests (CPET). Serial CPET are performed to prospectively measure changes in aerobic exercise capacity, and the MOS item short form health survey(SF-36)are constructed to survey life quality. What's more, echocardiography and NT-proBNP are also assessed.

Detailed Description

Acute myocardial infarction (AMI) is a life-threatening condition and a cause of functional disability, although reperfusion therapies and pharmacological strategies have been developed dramatically. Percutaneous coronary intervention(PCI)can effectively improve the myocardial blood supply of patients, However, various degrees of reduced exercise tolerance, anxiety and depression symptoms, impaired social function may occur after PCI and then lead to the decline of their quality of life. Exercise-based cardiopulmonary rehabilitation, which has beneficial effects on physical fitness, quality of life, cardiovascular risk factors and clinical outcome, is an important part of secondary prevention for patients after an acute myocardial infarction. Despite the evidence of these beneficial effects, cardiac rehabilitation programs are still largely underutilized and the exact benefits are still less well known. In this study, a randomized, controlled and prospective clinical trial is designed for patients with AMI to improve exercise capacity, cardiometabolic parameters, as well as quality of life by an individualized, low-cost exercise intervention we developed after evaluation by Cardiopulmonary Exercise Tests (CPET) . Serial CPET are performed to prospectively measure changes in aerobic exercise capacity, and the MOS item short form health survey(SF-36)are constructed to survey life quality. What's more, echocardiography and NT-proBNP are also assessed.

Registry
clinicaltrials.gov
Start Date
February 1, 2021
End Date
February 1, 2023
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Peak oxygen consumption (VO2)change

Time Frame: Baseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in peak VO2 comparing Experimental group with control.

Secondary Outcomes

  • oxygen consumption (VO2) at anaerobic threshold(Baseline, 3, 6 months)
  • Peak metabolic equivalent (MET) change(Baseline, 3, 6 months)
  • The MOS item short form health survey(SF-36)(Baseline, 3, 6 months)
  • Ventilatory efficiency (VE/VCO2 slope) change(Baseline, 3, 6 months)
  • Body mass index(BMI)change(Baseline, 3, 6 months)
  • LVEF change(Baseline, 3, 6 months)
  • Oxygen uptake related to work rate(ΔVO2/ΔWR)change(Baseline, 3, 6 months)
  • Peak /AT Oxygen Pulse (O2-Pulse)change(Baseline, 3, 6 months)
  • Heart rate variability(Baseline, 3, 6 months)
  • NT-proBNP(pg/ml)(Baseline, 3, 6 months)
  • The occurrence and composite of major adverse cardiac events (MACE)(3, 6 months)

Study Sites (1)

Loading locations...

Similar Trials